How Can Policymakers Support Pediatric Drug Development?
Policymakers can support pediatric drug development by continuing to offer incentives such as pediatric exclusivity and by providing grants for research. Additionally, creating regulations that streamline the approval process for pediatric drugs, while maintaining safety standards, can help facilitate the development and availability of pediatric-specific medications. Collaboration between government agencies, pharmaceutical companies, and healthcare providers is essential to address the unique needs of pediatric patients.
